Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients
Élisa Gobbini, Anne Claire Toffart, M. Pérol, Jean‐Baptiste Assié, M. Duruisseaux, Dahna Coupez, Cathérine Dubos, Virginie Westeel, Myriam Delaunay, Florian Guisier, Rémi Veillon, V. Gounant, Etienne Giroux‐Leprieur, François-Roger Vanel, Nouha Chaabane, Éric Dansin, Hélène Babey, C. Decroisette, Fabrice Barlési, Catherine Daniel, P. Fournel, Laura Mezquita, Youssef Oulkhouir, Anthony Canellas, Boris Duchemann, Olivier Molinier, Vincent Alcazer, Denis Moro‐Sibilot, Matteo Giaj Levra
Topics & Concepts
MedicineInternal medicineDiscontinuationOncologyLung cancerConfidence intervalPerformance statusRetrospective cohort studyHazard ratioInterquartile rangeCancerCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations